 Renovascular disease renal complications angiotensin-converting enzyme inhibitor therapy Renal complications angiotensin-converting enzyme ACE inhibitor therapy authors incidence spectrum conditions retrospective study consecutive patients unit acute uraemic emergencies six-year period cent renovascular disease responsible loss renal function Twenty-one cent patients uraemia attributable ACE inhibitor treatment cases significant renovascular pathology withdrawal ACE inhibitor renal failure majority patients consecutive hypertensive patients similar period vascular imaging cent patients renovascular pathology patients stable chronic renal disease deterioration glomerular filtration rate coincident commencement ACE inhibitor therapy agents observations significant renovascular disease common injudicious use ACE inhibitors serious complications Methods iatrogenic disease